ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 439,52
0,42%
Dow Jones
42 475,23
0,42%
DAX
20 247,34
0,55%
Brent Oil
79,455
-1,03%
Bitcoin
96 772,85
2,39%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. ProPhase Labs Inc (PRPH)

  7. ProPhase Labs Inc (PRPH) Actualités

PRPH

ProPhase Labs (PRPH)

ProPhase Labs Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:PRPH
DateHeureSourceTitreSymboleSociété
27/12/202423h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRPHProPhase Labs Inc
11/12/202414h00GlobeNewswire Inc.ProPhase Labs Secures Global Private Equity Backing, Nears Major Lozenge Deal, Adds Seasoned Industry Expert, and Plans Significant Cost-Cutting MeasuresNASDAQ:PRPHProPhase Labs Inc
21/11/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PRPHProPhase Labs Inc
19/11/202414h00GlobeNewswire Inc.Impact BioMedical Inc. Issues Shareholder Letter Highlighting Recent Achievements and Strategic VisionNASDAQ:PRPHProPhase Labs Inc
13/11/202422h49Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PRPHProPhase Labs Inc
13/11/202414h00GlobeNewswire Inc.ProPhase Labs Announces Financial Results for the Three Months Ended September 30, 2024NASDAQ:PRPHProPhase Labs Inc
12/11/202423h30Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:PRPHProPhase Labs Inc
12/11/202422h05GlobeNewswire Inc.ProPhase Labs Announces Closing of Public Offering of Common StockNASDAQ:PRPHProPhase Labs Inc
11/11/202415h52GlobeNewswire Inc.ProPhase Labs Inc. to Present Third Quarter 2024 Financial Results on November 13, 2024NASDAQ:PRPHProPhase Labs Inc
08/11/202422h05Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:PRPHProPhase Labs Inc
08/11/202405h37GlobeNewswire Inc.ProPhase Labs Announces Pricing of Public Offering of Common StockNASDAQ:PRPHProPhase Labs Inc
07/11/202422h05GlobeNewswire Inc.ProPhase Labs Announces Proposed Public Offering of Common StockNASDAQ:PRPHProPhase Labs Inc
04/11/202414h00GlobeNewswire Inc.ProPhase Labs Launches DNA Complete®: Transforming Direct-to-Consumer Genetic Testing for Health, Wellness, and Enhanced AncestryNASDAQ:PRPHProPhase Labs Inc
22/10/202414h00GlobeNewswire Inc.ProPhase Labs to Present at the 2024 ThinkEquity ConferenceNASDAQ:PRPHProPhase Labs Inc
17/10/202414h00GlobeNewswire Inc.ProPhase Labs Announces Positive Updates on Strategic Initiatives Company Anticipates Multiple Liquidity Events in H1 2025NASDAQ:PRPHProPhase Labs Inc
22/08/202412h07Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:PRPHProPhase Labs Inc
19/08/202417h10GlobeNewswire Inc.ProPhase Labs to Present at August 20th Virtual Investor Summit Microcap EventNASDAQ:PRPHProPhase Labs Inc
14/08/202414h00GlobeNewswire Inc.ProPhase Labs Announces Financial Results for the Three Months Ended June 30, 2024NASDAQ:PRPHProPhase Labs Inc
13/08/202414h00GlobeNewswire Inc.ProPhase Labs Announces Collaboration with Forward Healthcare Consultants to Aid in the Commercialization of its Billion Dollar Potential BE-Smart Esophageal Cancer TestNASDAQ:PRPHProPhase Labs Inc
09/08/202422h30Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:PRPHProPhase Labs Inc
07/08/202414h00GlobeNewswire Inc.PROPHASE LABS INC. TO PRESENT SECOND QUARTER 2024 FINANCIAL RESULTS ON AUGUST 14NASDAQ:PRPHProPhase Labs Inc
11/07/202414h00GlobeNewswire Inc.ProPhase Labs Announces Update on Pharmaloz Manufacturing, Inc. ProgressNASDAQ:PRPHProPhase Labs Inc
20/05/202422h20Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:PRPHProPhase Labs Inc
09/05/202421h40GlobeNewswire Inc.ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2024, and Highlights Significant Progress in its Strategic Initiatives. - UpdatedNASDAQ:PRPHProPhase Labs Inc
09/05/202414h00GlobeNewswire Inc.ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2024, and Highlights Significant Progress in its Strategic Initiatives.NASDAQ:PRPHProPhase Labs Inc
02/05/202414h00GlobeNewswire Inc.PROPHASE LABS INC. TO PRESENT FIRST QUARTER 2024 FINANCIAL RESULTS ON MAY 9NASDAQ:PRPHProPhase Labs Inc
25/04/202414h00GlobeNewswire Inc.ProPhase Labs to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024NASDAQ:PRPHProPhase Labs Inc
16/04/202414h00GlobeNewswire Inc.ProPhase Labs Unveils Project ZenQ-AINASDAQ:PRPHProPhase Labs Inc
10/04/202414h00GlobeNewswire Inc.ProPhase Labs Seeks to Transform Esophageal Cancer Detection and Management with Launch of its BE-Smart Test in H2 2024NASDAQ:PRPHProPhase Labs Inc
02/04/202403h00GlobeNewswire Inc.ProPhase Labs Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:PRPHProPhase Labs Inc
 Showing the most relevant articles for your search:NASDAQ:PRPH

Dernières Valeurs Consultées

NYSE
MRK
Merck
COIN
SOLUSD
Solana
EU
GLE
Societe Generale
COIN
XRPUSD
Ripple
EU
RI
Pernod Ricard
COIN
ADAUSD
Cardano
NASDAQ
MSFT
Microsoft
EU
PX4
SBF 120
COIN
DOGEUSD
Dogecoin
NASDAQ
AMZN
Amazon.com
SPI
SP500
S&P 500
EU
BNP
BNP Paribas
EU
CAP
Capgemini
EU
VIV
Vivendi
EU
ORA
Orange
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés